OPKO Health, Inc. (LON:0KCS)
1.501
-0.009 (-0.60%)
At close: Oct 15, 2025
OPKO Health Revenue
OPKO Health had revenue of $156.81M USD in the quarter ending June 30, 2025, a decrease of -13.93%. This brings the company's revenue in the last twelve months to $664.03M, down -7.31% year-over-year. In the year 2024, OPKO Health had annual revenue of $713.14M, down -17.41%.
Revenue (ttm)
$664.03M
Revenue Growth
-7.31%
P/S Ratio
1.86
Revenue / Employee
$221.56K
Employees
2,997
Market Cap
900.70M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
OPKO Health News
- 4 weeks ago - Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 2 months ago - Opko Health (OPK) Q2 Revenue Falls 14% - The Motley Fool
- 2 months ago - OPKO Health (OPK) Advances Strategic Initiatives with Key Asset Sale - GuruFocus
- 2 months ago - OPKO Health outlines $640M–$660M 2025 revenue target as BioReference sale and pipeline advances drive profitability push - Seeking Alpha
- 2 months ago - OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
- 3 months ago - NextPlat Issues Interim CEO Update Shareholder Letter - PRNewsWire
- 4 months ago - OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium - GlobeNewsWire